Markets•4 reports
32DOOM SCORE
Novartis shares plunge after study on del-desiran drug
Switzerland
First seen: Sep 8, 2026, 9:16 AM UTCUpdated: Sep 8, 2026, 4:31 PM UTC
WHAT HAPPENED
Novartis shares reportedly fell sharply after a study concerning the drug del-desiran. No size of the decline or study result is provided.
SO WHAT?
A major clinical setback could affect a large pharmaceutical company and expectations for a potential treatment.
FOR ME
Impact on Switzerland
Checking cached analysis...
MARKETS
Market impact
Checking cached analysis...
COVERAGE
Reports behind this event
finanznachrichten.dede
Aktien Wien Schluss: ATX geht unbewegt aus dem Handel
Sep 8, 2026, 4:31 PM UTC
aktiencheck.dede
Aktien Wien Schluss: ATX geht unbewegt aus dem Handel ()
Sep 8, 2026, 4:31 PM UTC
finanzen.netde
Aktien Schweiz von Novartis belastet
Sep 8, 2026, 4:01 PM UTC
watson.chde
Nach Studie zu Medikament Del-desiran: Novartis-Aktie stürzt ab
Sep 8, 2026, 9:16 AM UTC